Muscular Dystrophy Association Clinical and Scientific Conference

Dallas, TX

Benitec will deliver the following oral presentations:

  • Tuesday, March 18, 11:00am - 12:00pm CT, Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will be giving an oral presentation in the first session dedicated to OPMD at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference.
  • Wednesday, March 19, 1:15pm CT, An interim study update for the Phase 1b/2a Clinical Treatment Study of BB-301 in OPMD Subjects with moderate dysphagia will be presented in a late-breaking oral presentation entitled “Interim Study Update for the BB-301 Gene Therapy Phase 1b/2a First in Human Trial in Subjects with Oculopharyngeal Muscular Dystrophy with Dysphagia” in room Coronado ABCD.